Positive results from clinical trials exploring algal DHA supplementation during pregnancy and infancy were presented at the 10th Congress of the International Society for the Study of Fatty Acids and Lipids (ISSFAL) – an international scientific society focused on research of dietary fats, oils and lipids.
Research presented by Susan E. Carlson, PhD, at the Department of Dietetics and Nutrition at the University of Kansas Medical Center indicated that prenatal algal DHA supplementation (600 mg of DHA from 14 weeks gestation until delivery) increased DHA blood levels in both the mother and newborn, as well as infant birth weight, length and head circumference.
Additionally, results presented from a study led by Kelly Mulder and Sheila Innis, both from the Department of Pediatrics, Child and Family Research Institute at the University of British Colum-bia, suggest that DHA deficiency during pregnancy may limit infants’ development potential.
DHA is a polyunsaturated omega-3 fatty acid found throughout the body. It is a major structural fat in the brain and retina, accounting for up to 97 percent of the omega-3 fats in the brain and up to 93 percent of the omega-3 fats in the retina. Numerous studies confirm that everyone, from infants to adults, benefits from an adequate supply of DHA. Throughout every stage of life, DHA is proven to be important for brain and eye health.
life’sDHA™, used in the studies, is a vegetarian and sustainable source of DHA. It can be found in more than 550 products around the world, including supplements and fortified foods and beverages.